In vitro biological activity and structural analysis of 2,4-diamino-5-(2′-arylpropargyl)pyrimidine inhibitors of Candida albicans

被引：12

作者：

Paulsen, Janet L. ^{[1
]}

Liu, Jieying ^{[1
]}

Bolstad, David B. ^{[1
]}

Smith, Adrienne E. ^{[2
]}

Priestley, Nigel D. ^{[2
]}

Wright, Dennis L. ^{[1
]}

Anderson, Amy C. ^{[1
]}

机构：

[1] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA

[2] Univ Montana, Dept Chem, Missoula, MT 59812 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 14期

关键词：

Antifolate; Dihydrofolate reductase; Candida albicans; Molecular modeling; DIHYDROFOLATE-REDUCTASE; SELECTIVE INHIBITORS; CRYSTAL-STRUCTURES;

D O I：

10.1016/j.bmc.2009.06.021

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In order to develop new antifungal agents effective against two species of Candida, we have designed a series of dihydrofolate reductase (DHFR) inhibitors. Here, we explore the structure-activity relationships of these inhibitors toward Candida albicans DHFR by evaluating enzyme inhibition, antifungal activity and toxicity to mammalian cells. Analysis of docked complexes of the enzyme and inhibitors yields the structural basis of relative potency. The meta-biphenyl series of this class exhibits the greatest enzyme inhibition, selectivity and antifungal activity. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：4866 / 4872

页数：7

共 50 条

[21] CRYSTAL-STRUCTURE OF 2 LIPOPHILIC ANTIFOLATES - 2,4-DIAMINO-5-(N-HEXYL)-6-METHYLPYRIMIDINE AND 2,4-DIAMINO-5-(N-HEPTYL)-6-METHYLPYRIMIDINE ETHANESULFONATE
SUTTON, PA
CODY, V
JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1988, 18 (06): : 755 - 765
[22] DETERMINATION OF 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)-PYRIMIDINE (TRIMETHOPRIM) IN BLOOD AND URINE BY DIFFERENTIAL PULSE POLAROGRAPHY
BROOKS, MA
SILVA, JAFD
ARCONTE, LMD
ANALYTICAL CHEMISTRY, 1973, 45 (02) : 263 - 266
[23] Hydrogen-bonding patterns in trimethoprim perchlorate [trimethoprim=2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine]
Muthiah, PT
Umadevi, B
Stanley, N
Bocelli, G
Cantoni, A
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2002, 58 : O59 - O61
[24] Hydrogen bonding patterns in trimethoprim sulfate trihydrate [trimethoprim=2,4-diamino-5-(3,4,5-methoxybenzyl)pyrimidine]
Muthiah, PT
Umadevi, B
Stanley, N
Shui, XG
Eggleston, DS
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2001, 57 : O1179 - O1182
[25] APPLICATION OF NEURAL NETWORKS - QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF THE DERIVATIVES OF 2,4-DIAMINO-5-(SUBSTITUTED-BENZYL)PYRIMIDINES AS DHFR INHIBITORS
SO, SS
RICHARDS, WG
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (17) : 3201 - 3207
[26] ACTIONS OF 2,4-DIAMINO-5-(3',4'-DICHLOROPHENYL)-6-METHYLPYRIMIDINE IN MAMMALS
PHILIPS, FS
HAMILTON, LD
CLARKE, DA
STERNBERG, SS
HITCHINGS, GH
CANCER RESEARCH, 1952, 12 (04) : 287 - 288
[27] STRUCTURE ACTIVITY RELATIONS .12. ANTIBACTERIAL ACTIVITY OF A SERIES OF 2,4-DIAMINO-6-SUBSTITUTED-5-(4-PYRIDYLMETHYLAMINO)PYRIMIDINES AND 2,4-DIAMINO-5-(4-SUBSTITUTED BENZYLAMINO)PYRIMIDINES
BOWDEN, K
BRIGHT, AC
JOURNAL OF CHEMICAL RESEARCH-S, 1992, (02): : 51 - 51
[28] STRUCTURE OF 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE-5,5-DIETHYLBARBITURICACID (1-1)
SHIMIZU, N
NISHIGAKI, S
NAKAI, Y
OSAKI, K
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1982, 38 (AUG): : 2309 - 2311
[29] CRYSTALLINE STRUCTURE OF 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)-PYRIMIDINE-1-OXIDE DIHYDRATE (METABOLITE OF TRIMETHOPRIME)
OBERHANSLI, WE
HELVETICA CHIMICA ACTA, 1970, 53 (07) : 1787 - +
[30] Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors
Phuangsawai, Oraphan
Beswick, Paul
Ratanabunyong, Siriluk
Tabtimmai, Lueacha
Suphakun, Praphasri
Obounchoey, Phongphat
Srisook, Pimonwan
Horata, Natharinee
Chuckowree, Irina
Hannongbua, Supa
Ward, Simon E.
Choowongkomon, Kiattawee
Gleeson, M. Paul
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 124 : 896 - 905

← 1 2 3 4 5 →